drugset / Trial / NCT00690079
Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being performed in order to learn more about the safety and tolerability of AZD1386. AZD1386 is primary intended for treatment of chronic pain.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1386 | Small molecule | — | Oral |